Institute of Biomedical Technologies

Programmes, groups and research lines

The research groups at the ITB are comprised of teaching and research staff who come together to study specific research lines of interest. It is understood that the members of a group collaborate effectively, participating in common projects, as witnessed by the record of joint publications of sufficient quality and volume to satisfy the demands of the Executive Commission. Every research group must maintain a project that receives significant external funding, led by a researcher with a clear trajectory in the particular area of research, although emerging groups applying for public competitive calls for the first time may be considered as special cases. Following the strategic analyses of the past few years, the activities at the ITB were recently restructured into four research programmes (see below), with a view to applying for status as a “María de Maeztu” Unit of Excellence in the 2019 call.

In addition, the Institute also integrates research groups that work in complementary areas and that have the potential to collaborate in developing research lines, or that provide services to members of the Institute, such as laboratories and associated units from the Biomedical Innovation Platform.

In the description of each group, all the members considered formal members of the Institute are listed, including PIs, Associated Researchers and researchers in trainning. Each group also includes external collaborators and assistant researchers who are not formal members of the Institute.


This programme has been designed based on the history and geographical circumstances of the Canary Islands. The current genome of the Canarian population is inherited from the aboriginal people of North Africa and from the European population since the 15th century, making it a unique worldwide genome. In addition, there are a number of pathologies seen in the islands that exhibit a genetic component influenced by the insular concept, due to a founder effect and the lack of infrastructures that in the past favored endogamy. The research groups involved in this programme focus on studying the molecular bases of cancer and rare metabolic diseases. Cancer research is aimed at prevention, diagnosis, the identification of the biological causes and the development of effective treatments, with the ultimate goal that this serious health problem should become a chronic condition as opposed to a fatal one. On the other hand, although individual rare diseases affect only a limited fraction of the population (less than 2,000 people in Europe), the number of different diseases is very high (more than 5,000) and the total number of patients exceeds 30 million in the European Union. This arm of the programme, pursues medium and long-term goals, such as the development of personalised medicines and a reinforcement of the collaborations with industry.

Groups ( click for more information)

This programme has recently been created to promote the development of projects focused on the search for new compounds with therapeutic potential, new drug delivery systems and the identification of pharmacological targets. This programme brings together three research teams that use complementary approaches and numerous collaborations with groups from the other three programmes of the Institute.

Groups (click for more information)